Canada Life’s Arrowhead Research ARWR Stock Holding History

Canada Life’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.07M	Sell	80,807 -37,943	-32%	-$2.4M	0.01%	741
2025 Q4	$7.88M	Sell	118,750 -11,208	-9%	-$549K	0.01%	578
2025 Q3	$4.39M	Buy	129,958 +13,653	+12%	+$300K	0.01%	870
2025 Q2	$1.84M	Sell	116,305 -1,867	-2%	-$26.8K	﹤0.01%	1224
2025 Q1	$1.5M	Buy	118,172 +17,583	+17%	+$320K	﹤0.01%	1302
2024 Q4	$1.89M	Sell	100,589 -5,122	-5%	-$105K	﹤0.01%	1290
2024 Q3	$2.05M	Buy	105,711 +3,620	+4%	+$88.3K	﹤0.01%	1286
2024 Q2	$2.65M	Buy	102,091 +11,520	+13%	+$283K	0.01%	1142
2024 Q1	$2.59M	Buy	90,571 +8,065	+10%	+$258K	0.01%	1121
2023 Q4	$2.52M	Sell	82,506 -2,047	-2%	-$54.4K	0.01%	1130
2023 Q3	$2.27M	Buy	84,553 +7,136	+9%	+$219K	0.01%	1143
2023 Q2	$2.77M	Sell	77,417 -6,004	-7%	-$207K	0.01%	1020
2023 Q1	$2.12M	Buy	83,421 +12,291	+17%	+$387K	0.01%	1206
2022 Q4	$2.88M	Buy	71,130 +7,303	+11%	+$242K	0.01%	1032
2022 Q3	$2.11M	Sell	63,827 -1,065	-2%	-$43K	0.01%	1144
2022 Q2	$2.28M	Buy	64,892 +7,738	+14%	+$291K	0.01%	1101
2022 Q1	$2.7M	Buy	57,154 +4,899	+9%	+$243K	0.01%	1052
2021 Q4	$3.46M	Buy	52,255 +3,339	+7%	+$229K	0.01%	898
2021 Q3	$3.08M	Buy	48,916 +8,841	+22%	+$572K	0.01%	912
2021 Q2	$3.32M	Buy	40,075 +239	+0.6%	+$17.8K	0.01%	848
2021 Q1	$2.64M	Sell	39,836 -3,157	-7%	-$245K	0.01%	958
2020 Q4	$3.3M	Sell	42,993 -5,057	-11%	-$323K	0.01%	902
2020 Q3	$2.06M	Sell	48,050 -7,492	-13%	-$323K	﹤0.01%	1046
2020 Q2	$2.4M	Buy	55,542 +2,024	+4%	+$71.4K	0.01%	980
2020 Q1	$1.54M	Buy	53,518 +5,598	+12%	+$226K	﹤0.01%	1087
2019 Q4	$3.02M	Buy	+47,920	New	+$2.38M	0.01%	908
2019 Q3	–	Sell	-127,402	Closed	-$3.38M	–	1194
2019 Q2	$3.38M	Buy	127,402 +115,704	+989%	+$2.54M	0.01%	902
2019 Q1	$214K	Buy	11,698 +3,916	+50%	+$64.6K	﹤0.01%	1859
2018 Q4	$93K	Hold	7,782	–	–	﹤0.01%	2166
2018 Q3	$149K	Hold	7,782	–	–	﹤0.01%	2075
2018 Q2	$106K	Buy	+7,782	New	+$72.7K	﹤0.01%	2166
2017 Q2	–	Sell	-5,700	Closed	-$11K	–	2541
2017 Q1	$11K	Hold	5,700	–	–	﹤0.01%	2493
2016 Q4	$9K	Hold	5,700	–	–	﹤0.01%	2523
2016 Q3	$42K	Hold	5,700	–	–	﹤0.01%	2363
2016 Q2	$30K	Hold	5,700	–	–	﹤0.01%	2420
2016 Q1	$27K	Hold	5,700	–	–	﹤0.01%	2303
2015 Q4	$35K	Hold	5,700	–	–	﹤0.01%	2258
2015 Q3	$33K	Hold	5,700	–	–	﹤0.01%	2225
2015 Q2	$41K	Hold	5,700	–	–	﹤0.01%	2298
2015 Q1	$38K	Hold	5,700	–	–	﹤0.01%	2194
2014 Q4	$42K	Hold	5,700	–	–	﹤0.01%	2157
2014 Q3	$85K	Buy	+5,700	New	+$77.9K	﹤0.01%	1804

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Canada Life's ARWR Position: Q1 2026 in Review

Canada Life reduced its Arrowhead Research (ARWR) stake by 32% in Q1 2026, selling an estimated $2.4M and leaving 80,807 shares worth $5.07M. The position accounts for 0.01% of the portfolio, ranked #741.

Canada Life first reported a position in ARWR in Q3 2014 and has held it in 42 quarters since. The position peaked at $7.88M in Q4 2025. 436 funds tracked by Wall St. Rank hold ARWR as of Q1 2026.

Canada Life held 80,807 shares of Arrowhead Research worth $5.07M as of Q1 2026.
Canada Life sold 37,943 Arrowhead Research shares in Q1 2026, an estimated $2.4M.
Arrowhead Research made up 0.01% of Canada Life's portfolio in Q1 2026, its #741 holding.
Canada Life first reported a position in Arrowhead Research in Q3 2014 and has held it in 42 quarters since.
Canada Life's Arrowhead Research position peaked at $7.88M in Q4 2025.
436 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.